The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Adaptimmune; Forty Seven; Hylapharm; Ignyta; Loxo; Zymeworks (I)
Research Funding - Astellas Pharma; Exelis; Incyte; Lilly; Pfizer; Regeneron; Tolero Pharmaceuticals; Xencor
Travel, Accommodations, Expenses - Sanofi
EV-202: A phase II study of enfortumab vedotin in patients with select previously treated locally advanced or metastatic solid tumors.
 
Justine Yang Bruce
Leadership - ImageMoverMD (I)
Stock and Other Ownership Interests - ImageMoverMD (I)
Consulting or Advisory Role - Genzyme
Research Funding - Kura Oncology (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Sensei Biotherapeutics (Inst)
 
Lajos Pusztai
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Athenex; Bristol-Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Genentech (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - NanoString Technologies
 
Fadi S. Braiteh
Honoraria - Abbott Nutrition; Amgen; ARIAD; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech/Roche; HERON; Immunomedics; Incyte; Insys Therapeutics; Ipsen; Lexicon; Lilly; Puma Biotechnology; Taiho Pharmaceutical
Consulting or Advisory Role - Ambry Genetics; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Ipsen; Lexicon; Lilly; Merck; Merrimack; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Seema Rao Gorla
Employment - Astellas Pharma
Other Relationship - Astellas Pharma
 
Chunzhang Wu
Employment - Astellas Pharma
 
Joaquina Baranda
No Relationships to Disclose